Drug Description in Trials / DrugBank / KEGG DRUG


Search results


No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1Tralesinidase alfa
(D13342)
[1] Tralesinidase alfa[1] Tralesinidase alfa (D13342) 💬 [2] IGF2,
NAGLU 💬
[9] Glycosaminoglycan degradation, Hepatocellular carcinoma, Hormone signaling, Lysosome biogenesis, MAPK signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer, Proteoglycans in cancer, Ras signaling pathway 💬[1] 19 💬
2Tralesinidase alfa (TA)
(D13342)
[1] Tralesinidase alfa[1] Tralesinidase alfa (D13342) 💬 [2] IGF2,
NAGLU 💬
[9] Glycosaminoglycan degradation, Hepatocellular carcinoma, Hormone signaling, Lysosome biogenesis, MAPK signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer, Proteoglycans in cancer, Ras signaling pathway 💬[1] 19 💬